TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225. January 4, 2002